Literature DB >> 25682237

Galleria mellonella as an in vivo model for assessing the efficacy of antimicrobial agents against Enterobacter cloacae infection.

Hai-Fei Yang1, Ai-Jun Pan2, Li-Fen Hu1, Yan-Yan Liu3, Jun Cheng1, Ying Ye4, Jia-Bin Li5.   

Abstract

BACKGROUND/
PURPOSE: Enterobacter cloacae is a well-recognized nosocomial pathogen. Use of a rapid, in vivo infection model for E. cloacae that can determine the efficacy of antibiotic therapies could help facilitate screening for new treatments. Nonmammalian model systems of infection, such as Galleria mellonella, have significant logistical and ethical advantages over mammalian models.
MATERIALS AND METHODS: We utilized G. mellonella larvae to determine the utility of this infection model to study antibacterial efficacy. G. mellonella killing with heat-killed or live clinical isolates (E. cloacae GN1059 and GN0791) was tested. We also investigated the effect of postinoculation incubation temperature on the survival of infected larvae. The protection of administration of antibiotics to infected larvae was investigated. Finally, we determined the G. mellonella hemolymph burden of E. cloacae after administration of different antibiotics.
RESULTS: With live bacterial inocula, G. mellonella killing was significantly dependent on the number of E. cloacae cells injected in a dose-dependent manner. Further, we observed that survival was reduced with increasing the postinoculation temperature. Treatment of a lethal E. cloacae infection with antibiotics that had in vitro activity significantly prolonged the survival of larvae compared with treatment with antibiotics to which the bacteria were resistant. The therapeutic benefit arising from administration of antibiotic correlated with a reduced burden of E. cloacae cells in the hemolymph.
CONCLUSION: The G. mellonella infection model has the potential to be used to facilitate the in vivo study of host-pathogen interactions in E. cloacae and the efficacy of antibacterial agents.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Enterobacter cloacae; antibacterial; antimicrobial; drug resistance; insect infection model

Mesh:

Substances:

Year:  2014        PMID: 25682237     DOI: 10.1016/j.jmii.2014.11.011

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  12 in total

1.  Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus.

Authors:  Yaowen Li; Yu Peng; Na Zhang; Huiping Liu; Jun Mao; Yisong Yan; Shuaishuai Wang; Guang Yang; Yanyan Liu; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2022-08-30       Impact factor: 4.177

2.  The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence.

Authors:  Wenrui Gu; Dongmei Guo; Liuping Zhang; Dongmei Xu; Shujuan Sun
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance.

Authors:  Ulrike Binder; Maria Aigner; Brigitte Risslegger; Caroline Hörtnagl; Cornelia Lass-Flörl; Michaela Lackner
Journal:  J Fungi (Basel)       Date:  2019-09-04

4.  Comparative Analysis of Adelphocoris suturalis Jakovlev (Hemiptera: Miridae) Immune Responses to Fungal and Bacterial Pathogens.

Authors:  Meiqi Ma; Libin Guo; Chengjie Tu; Aoli Wang; Letian Xu; Jing Luo
Journal:  Front Physiol       Date:  2021-03-18       Impact factor: 4.566

Review 5.  Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future.

Authors:  Guillaume Ménard; Astrid Rouillon; Vincent Cattoir; Pierre-Yves Donnio
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

6.  Punica granatum L. (Pomegranate) Extract: In Vivo Study of Antimicrobial Activity against Porphyromonas gingivalis in Galleria mellonella Model.

Authors:  Livia Aparecida Procópio Gomes; Lívia Mara Alves Figueiredo; Ana Luiza do Rosário Palma; Barbara Maria Corrêa Geraldo; Kelly Cristine Isler Castro; Luciana Ruano de Oliveira Fugisaki; Antônio Olavo Cardoso Jorge; Luciane Dias de Oliveira; Juliana Campos Junqueira
Journal:  ScientificWorldJournal       Date:  2016-09-07

7.  Resurrection of Nalidixic Acid: Evaluation of Water-Based Nanoformulations as Potential Nanomedicine.

Authors:  Alka Pandey; Nisha Aggarwal; Alok Adholeya; Mandira Kochar
Journal:  Nanoscale Res Lett       Date:  2018-09-24       Impact factor: 4.703

8.  The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant Staphylococcus aureus.

Authors:  Nagendran Tharmalingam; Rajamohammed Khader; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Front Microbiol       Date:  2019-07-17       Impact factor: 5.640

Review 9.  Innate humoral immune defences in mammals and insects: The same, with differences ?

Authors:  Gerard Sheehan; Amy Garvey; Michael Croke; Kevin Kavanagh
Journal:  Virulence       Date:  2018       Impact factor: 5.882

10.  Establishing an invertebrate Galleria mellonella greater wax moth larval model of Neisseria gonorrhoeae infection.

Authors:  Aiste Dijokaite; Maria Victoria Humbert; Emma Borkowski; Roberto M La Ragione; Myron Christodoulides
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.